| GSK1904529A |
ENSG00000117242.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000124835.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000124835.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000125514.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000126005.11 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000146666.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000157306.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000170161.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000170161.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000170161.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000170590.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000172965.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000173867.8 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000175611.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000175701.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000175701.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000175773.8 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000175873.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000177133.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000177738.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000177822.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000177822.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000177822.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000178440.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000178803.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000179406.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000179818.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000179818.9 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000179859.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000180279.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000180846.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000180846.4 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000181800.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000182057.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000182109.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000182109.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000182109.3 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000182165.13 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000182165.13 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000182376.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000182873.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000184274.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000184274.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000184274.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000185203.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000186056.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000186056.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000186615.6 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000188206.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000189223.9 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000196559.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000196559.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000196810.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000196951.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000196951.6 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000196960.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000196972.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000197210.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000197291.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000197291.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000197308.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000197332.7 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000197670.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000198106.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000203280.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000203288.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000203325.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000203362.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000203441.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000203496.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000203497.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000203650.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000203849.6 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000203875.6 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000204362.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000204380.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000204380.2 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000204581.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000204685.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000204706.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000204791.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000204802.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000204802.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000204837.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000204934.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000204934.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000205424.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000205500.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000205632.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000205885.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000205890.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000205913.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000205959.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000206195.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000206337.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000206417.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000211683.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000212978.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000213793.3 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000213963.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000214347.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000214432.5 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000214650.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000214650.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000214725.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000214733.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000214770.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000214770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000215022.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000215039.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000215068.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000215244.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000215394.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000215424.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000215447.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000215533.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000215692.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000215866.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000217576.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000217576.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000220161.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000222041.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000223379.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000223380.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000223382.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000223462.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000223477.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000223522.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000223546.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000223571.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000223571.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000223571.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000223579.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000223695.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000223697.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000223701.3 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000223711.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000223711.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000223715.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000223725.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000223734.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000223745.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000223764.2 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000223834.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000223911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000223960.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000224031.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000224031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000224043.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000224078.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000224099.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000224220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000224259.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000224276.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000224281.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000224310.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000224349.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000224356.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000224363.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000224376.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000224387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000224505.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000224536.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000224541.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000224541.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000224614.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000224635.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000224649.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000224699.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000224713.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000224713.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000224761.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000224789.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000224814.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000224818.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000224848.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000224863.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000224884.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000224888.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000224897.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000224934.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000224939.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000225030.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000225075.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000225075.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000225077.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000225111.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000225152.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000225163.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000225163.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000225163.3 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000225173.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000225210.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000225218.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000225234.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000225235.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000225235.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000225255.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000225278.3 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000225300.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000225331.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000225335.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000225335.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000225377.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000225470.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000225479.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000225643.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000225649.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000225675.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000225684.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000225839.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000225839.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000225880.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000225889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000225889.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000225891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000225891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000225930.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000225937.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000225945.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000225945.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000225953.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000225973.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000225981.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000225981.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000226029.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000226053.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000226067.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000226088.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000226088.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000226089.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000226091.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000226155.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000226245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000226263.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000226291.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000226291.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000226312.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000226330.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000226375.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000226390.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000226455.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000226562.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000226581.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000226649.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000226702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000226746.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000226772.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000226786.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000226791.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000226852.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000226862.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000226883.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000226891.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000226904.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000226920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000226935.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000226944.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000226944.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000226954.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000227006.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000227036.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000227036.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000227050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000227060.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000227060.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000227071.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000227082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000227083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000227172.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000227172.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000227193.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000227210.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000227214.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000227214.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000227214.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000227214.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000227215.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000227218.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000227237.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000227248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000227258.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000227285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000227354.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000227354.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000227359.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000227359.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000227375.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000227392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000227432.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000227438.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000227479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000227484.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000227484.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000227487.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000227495.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000227495.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000227502.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000227512.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000227512.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000227518.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000227518.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000227542.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000227543.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000227589.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000227627.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000227685.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000227698.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000227741.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000227811.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000227895.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000227896.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000227932.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000227959.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000227963.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000228013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000228028.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000228063.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000228065.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000228079.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000228084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000228109.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000228113.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000228115.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000228139.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000228192.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000228192.3 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000228274.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000228294.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000228302.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000228313.3 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000228315.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000228350.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000228350.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000228350.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000228353.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000228386.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000228389.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000228393.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000228414.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000228420.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000228437.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000228444.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000228444.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000228452.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000228470.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000228487.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000228540.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000228544.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000228544.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000228573.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000228577.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000228604.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000228624.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000228629.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000228649.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000228686.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000228709.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000228737.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000228786.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000228793.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000228800.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000228802.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000228802.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000228839.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000228852.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000228857.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000228857.2 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000228878.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000228939.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000229036.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000229043.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000229081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000229127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000229152.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000229162.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000229178.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000229195.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000229243.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000229267.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000229278.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000229323.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000229327.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000229331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000229393.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000229454.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000229454.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000229498.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000229512.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000229521.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000229536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000229582.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000229582.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000229587.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000229666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000229697.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000229751.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000229801.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000229852.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000229867.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000229869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000229891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000229950.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000229951.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000229955.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000229955.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000229980.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000229999.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000229999.2 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000230005.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000230013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000230015.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000230068.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000230068.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000230082.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000230102.3 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000230126.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000230131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000230131.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000230177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000230303.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000230309.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000230310.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000230310.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000230337.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000230337.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000230337.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000230337.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000230366.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000230368.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000230415.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000230438.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000230470.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000230498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000230526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000230530.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000230530.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000230530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000230534.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000230536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000230555.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000230565.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000230612.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000230612.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000230613.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000230648.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000230649.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000230729.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000230729.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000230730.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000230732.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000230735.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000230736.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000230747.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000230798.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000230806.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000230812.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000230844.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000230844.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000230914.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000230922.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000230937.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000231010.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000231025.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000231104.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000231104.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000231128.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000231128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000231133.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000231154.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000231154.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000231172.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000231172.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000231193.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000231196.3 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000231201.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000231212.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000231233.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000231242.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000231249.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000231249.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000231305.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000231305.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000231327.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000231393.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000231439.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000231473.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000231473.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000231485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000231528.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000231532.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000231563.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000231566.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000231595.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000231607.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000231607.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000231609.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000231609.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000231611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000231636.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000231728.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000231731.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000231811.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000231826.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000231840.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000231842.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000231856.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000231889.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000231889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000231889.3 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000231903.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000231903.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000231920.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000231971.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000231992.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000231999.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000232019.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000232044.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000232063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000232063.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000232104.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000232224.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000232295.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000232300.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000232377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000232445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000232487.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000232527.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000232527.3 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000232539.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000232586.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000232586.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000232611.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000232611.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000232613.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000232645.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000232645.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000232648.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000232677.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000232677.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000232677.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000232725.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000232725.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000232729.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000232729.3 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000232732.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000232828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000232874.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000232876.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000232909.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000232931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000232998.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000233016.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000233033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000233038.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000233058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000233060.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000233081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000233098.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000233144.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000233144.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000233178.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000233178.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000233237.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000233242.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000233246.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000233255.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000233396.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000233396.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000233411.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000233421.3 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000233427.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000233461.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000233496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000233509.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000233554.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000233593.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000233613.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000233613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000233621.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000233621.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000233651.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000233723.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000233754.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000233757.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000233757.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000233757.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000233775.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000233797.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000233800.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000233806.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000233825.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000233845.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000233862.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000233871.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000233885.3 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000233901.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000233903.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000233953.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000233967.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000233967.2 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000234037.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000234072.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000234084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000234084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000234129.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000234129.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000234160.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000234185.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000234197.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000234199.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000234230.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000234255.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000234281.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000234327.3 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000234393.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000234405.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000234428.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000234449.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000234459.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000234459.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000234478.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000234478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000234492.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000234509.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000234509.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000234577.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000234616.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000234617.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000234630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000234650.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000234665.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000234689.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000234694.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000234705.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000234840.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000234869.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000234899.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000234912.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000234913.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000234917.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000234917.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000234944.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000234945.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000235051.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000235052.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000235070.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000235077.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000235078.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000235100.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000235117.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000235142.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000235159.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000235159.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000235159.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000235192.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000235204.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000235204.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000235214.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000235214.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000235236.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000235245.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000235285.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000235381.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000235387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000235423.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000235426.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000235461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000235475.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000235494.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000235530.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000235570.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000235586.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000235621.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000235629.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000235665.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000235726.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000235770.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000235770.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000235770.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000235781.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000235806.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000235831.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000235852.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000235852.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000235884.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000235890.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000235897.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000235903.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000235908.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000235910.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000235910.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000235919.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000235919.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000235927.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000236008.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000236017.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000236045.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000236066.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000236088.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000236115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000236140.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000236144.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000236153.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000236166.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000236194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000236212.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000236266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000236308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000236337.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000236358.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000236364.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000236384.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000236390.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000236427.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000236434.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000236467.3 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000236498.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000236526.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000236528.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000236528.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000236540.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000236548.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000236559.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000236591.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000236611.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000236618.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000236711.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000236711.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000236772.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000236824.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000236859.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000236869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000236869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000236869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000236901.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000236977.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000237017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000237021.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000237021.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000237021.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000237073.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000237159.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000237159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000237222.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000237253.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000237291.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000237298.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000237301.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000237359.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000237371.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000237402.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000237410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000237424.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000237424.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000237436.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000237438.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000237438.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000237457.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000237471.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000237489.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000237517.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000237525.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000237594.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000237605.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000237646.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000237658.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000237686.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000237686.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000237697.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000237718.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000237768.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000237773.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000237781.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000237805.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000237836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000237883.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000237940.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000237945.3 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000237976.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000238045.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000238062.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000238068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000238078.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000238113.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000238123.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000238123.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000238133.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000238140.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000238142.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000238186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000238186.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000238198.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000239002.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000239219.2 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000239335.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000239407.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000239415.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000239636.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000239674.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000239674.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000239774.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000239941.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000239994.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000240050.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000240057.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000240288.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000240373.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000240401.4 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000240449.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000240498.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000240553.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000240571.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000240571.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000240571.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000240758.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000240859.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000240915.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000240996.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000241054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000241125.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000241163.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000241169.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000241219.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000241280.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000241313.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000241316.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000241316.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000241570.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000241769.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000241770.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000241772.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000241956.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000241990.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000242078.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000242086.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000242094.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000242104.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000242125.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000242190.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000242622.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000242686.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000242798.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000242798.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000243008.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000243107.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000243150.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000243176.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000243187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000243243.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000243389.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000243433.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000243433.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000243479.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000243533.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000243637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000243701.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000243960.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000244063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000244184.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000244327.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000244327.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000244332.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000244349.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000244349.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000244586.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000244675.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000244757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000244879.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000244926.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000244952.2 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000245059.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000245059.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000245148.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000245330.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000245526.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000245556.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000245571.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000245571.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000245573.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000245685.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000245694.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000245711.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000245711.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000245748.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000245768.2 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000245849.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000245857.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000245904.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000246130.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000246130.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000246334.2 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000246339.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000246422.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000246451.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000246451.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000246465.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000246526.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000246582.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000246731.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000246777.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000246792.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000246792.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000246859.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000246863.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000246877.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000247081.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000247092.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000247092.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000247134.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000247137.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000247199.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000247213.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000247240.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000247324.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000247363.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000247373.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000247373.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000247556.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000247624.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000247624.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000247679.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000247708.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000247708.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000247735.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000247774.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000247809.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000247877.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000247950.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000247970.2 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000248008.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000248027.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000248079.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000248131.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000248161.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000248254.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000248265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000248367.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000248399.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000248475.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000248516.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000248538.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000248544.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000248554.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000248576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000248587.2 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000248596.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000248597.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000248607.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000248668.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000248668.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000248714.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000248719.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000248730.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000248773.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000248774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000248774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000248846.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000248896.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000248936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000248980.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000249084.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000249084.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000249096.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000249207.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000249207.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000249249.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000249249.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000249304.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000249309.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000249388.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000249417.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000249494.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000249509.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000249509.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000249592.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000249592.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000249602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000249609.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000249631.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000249637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000249641.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000249655.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000249655.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000249664.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000249684.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000249685.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000249740.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000249753.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000249790.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000249791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000249816.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000249896.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000250015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000250046.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000250056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000250081.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000250106.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000250155.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000250240.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000250260.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000250366.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000250378.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000250404.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000250404.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000250410.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000250432.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000250509.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000250519.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000250546.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000250548.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000250659.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000250714.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000250734.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000250742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000250786.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000250802.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000250889.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000250893.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000250909.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000250909.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000250950.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000250988.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000250990.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000251003.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000251010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000251018.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000251023.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000251131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000251131.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000251136.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000251141.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000251141.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000251143.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000251151.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000251169.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000251221.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000251298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000251363.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000251408.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000251450.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000251497.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000251523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000251532.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000251562.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000251603.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000251603.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000251666.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000251687.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000251867.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000253121.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000253174.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000253174.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000253197.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000253230.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000253284.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000253307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000253315.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000253317.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000253317.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000253339.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000253395.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000253477.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000253513.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000253513.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000253559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000253563.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000253576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000253603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000253616.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000253618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000253636.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000253701.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000253706.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000253736.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000253738.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000253741.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000253744.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000253754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000253829.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000253854.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000253859.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000253865.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000253878.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000253930.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000253948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000253955.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000253965.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000253973.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000253978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000253982.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000254027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000254042.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000254094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000254099.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000254101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000254109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000254109.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000254180.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000254207.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000254208.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000254208.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000254263.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000254288.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000254319.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000254341.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000254353.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000254363.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000254370.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000254397.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000254427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000254451.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000254459.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000254468.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000254477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000254495.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000254495.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000254510.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000254533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000254556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000254560.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000254574.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000254577.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000254606.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000254671.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000254676.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000254691.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000254694.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000254694.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000254812.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000254826.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000254842.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000254846.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000254854.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000254869.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000254880.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000254900.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000254900.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000254907.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000254910.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000254911.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000254936.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000254938.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000254966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000255027.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000255027.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000255090.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000255119.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000255121.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000255133.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000255176.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000255216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000255234.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000255248.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000255306.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000255310.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000255320.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000255334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000255343.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000255343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000255343.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000255355.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000255427.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000255434.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000255449.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000255449.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000255458.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000255474.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000255474.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000255503.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000255520.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000255521.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000255539.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000255557.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000255557.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000255559.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000255571.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000255571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000255650.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000255651.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000255670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000255693.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000255717.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000255741.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000255808.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000255843.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000255847.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000255847.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000255857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000255933.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000255946.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000255968.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000255989.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000256008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000256124.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000256150.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000256195.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000256196.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000256271.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000256278.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000256381.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000256442.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000256442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000256481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000256538.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000256564.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000256582.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000256588.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000256603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000256712.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000256746.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000256747.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000256757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000256789.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000256824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000256862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000256955.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000256967.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000256973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000257004.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000257027.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000257052.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000257086.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000257126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000257151.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000257167.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000257185.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000257191.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000257202.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000257264.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000257272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000257285.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000257298.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000257381.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000257475.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000257475.2 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000257507.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000257509.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000257527.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000257543.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000257551.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000257595.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000257605.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000257621.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000257621.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000257647.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000257660.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000257696.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000257702.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000257702.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000257711.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000257740.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000257742.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000257769.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000257808.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000257815.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000257877.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000257964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000258001.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000258096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000258168.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000258199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000258260.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000258260.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000258301.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000258302.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000258303.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000258303.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000258344.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000258422.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000258428.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000258428.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000258441.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000258442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000258450.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000258499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000258515.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000258520.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000258520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000258520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000258525.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000258525.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000258525.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000258545.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000258556.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000258561.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000258561.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000258592.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000258620.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000258633.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000258633.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000258636.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000258642.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000258658.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000258682.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000258682.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000258689.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000258711.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000258733.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000258735.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000258766.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000258821.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000258821.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000258825.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000258851.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000258858.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000258871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000258904.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000258904.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000258904.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000258910.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000258935.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000258935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259001.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000259054.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000259088.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000259088.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000259138.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000259138.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000259146.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259153.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259163.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259212.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000259218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259241.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259250.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259274.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000259287.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000259287.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000259296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259310.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000259310.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000259327.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000259341.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000259343.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000259362.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000259372.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000259372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259376.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000259380.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000259408.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000259410.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000259416.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000259417.2 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000259418.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259418.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259422.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000259423.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000259424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259424.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000259442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259442.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000259448.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259448.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000259456.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000259485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259488.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000259508.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259514.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259523.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000259551.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000259551.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000259551.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259553.2 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000259563.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000259563.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000259589.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259595.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000259606.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000259618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259631.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259644.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000259645.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000259664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259668.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259668.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000259692.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000259705.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259715.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259725.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259744.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000259755.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000259763.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000259772.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259783.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000259788.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000259793.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259797.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000259799.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000259804.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259804.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000259818.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000259820.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000259834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259863.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259876.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259876.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000259877.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000259883.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000259891.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000259894.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000259920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259921.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000259933.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000259953.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259957.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000259959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259994.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000259999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260022.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260030.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260034.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000260034.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260046.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000260063.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000260081.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000260081.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000260083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000260084.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000260086.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000260093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260095.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000260118.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260123.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260132.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260136.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000260145.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000260167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260176.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000260196.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000260196.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260233.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000260249.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000260252.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000260257.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260273.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000260273.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000260277.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000260281.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000260285.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000260293.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260306.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000260317.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000260336.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260361.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260364.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260388.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260404.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000260411.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260418.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000260423.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000260423.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000260425.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000260469.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260470.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000260495.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000260495.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260515.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000260526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260534.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000260536.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260545.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000260563.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000260583.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260583.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260589.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260591.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000260601.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260608.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000260614.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260616.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000260626.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000260630.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000260633.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260641.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000260641.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260645.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000260655.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000260664.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000260671.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260672.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000260693.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260693.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000260698.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000260743.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000260743.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260773.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000260777.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000260790.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000260796.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000260805.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000260805.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260830.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000260831.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260834.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260871.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260874.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000260884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260891.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000260895.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000260905.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000260919.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000260920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260924.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260926.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260936.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000260936.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000260936.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000260941.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000260942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260947.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000260948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260949.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260954.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000260973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000260973.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000260992.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261002.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000261008.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000261024.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261033.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000261051.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000261055.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261064.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261064.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000261069.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261069.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000261087.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000261094.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000261098.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000261098.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261114.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000261123.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000261135.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261141.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261167.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000261187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261188.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261195.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000261200.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000261204.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000261204.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000261227.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261242.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000261248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261251.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261266.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000261266.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000261270.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000261288.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000261305.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000261326.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261329.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261357.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000261420.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261428.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000261430.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000261433.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261435.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000261442.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000261451.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261455.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000261462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261471.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261476.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000261478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261488.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261490.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000261496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261533.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261533.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000261533.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000261542.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000261613.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000261655.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000261663.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000261663.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261669.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000261669.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261685.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261729.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000261766.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000261777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261780.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000261783.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261799.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000261799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261839.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000261840.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000261924.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000261924.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000261971.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000262089.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000262115.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000262136.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000262147.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000262222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000262228.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000262228.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000262265.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000262410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000262410.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000262434.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000262686.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000262703.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000262768.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000262848.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000262848.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000262903.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000262921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000262951.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000262966.2 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000262979.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000263013.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000263013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000263080.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000263105.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000263105.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000263105.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000263220.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000263272.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000263307.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000263307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000263316.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000263331.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000263345.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000263350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000263466.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000263603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000263624.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000263680.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000263717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000263859.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000263862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000263906.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000263906.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000263916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000263916.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000263924.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000263931.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000264007.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000264012.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000264031.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000264043.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000264043.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000264167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000264196.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000264270.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000264290.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000264304.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000264304.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000264339.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000264365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000264365.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000264448.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000264469.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000264635.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000264808.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000264860.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000264860.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000264860.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000264920.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000265008.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000265043.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000265128.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000265130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000265148.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000265148.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000265185.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000265205.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000265222.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000265334.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000265394.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000265443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000265443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000265458.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000265474.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000265479.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000265496.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000265511.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000265542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000265656.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000265752.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000265787.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000265791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000265800.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000266010.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000266040.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000266236.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000266236.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000266289.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000266290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000266313.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000266340.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000266340.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000266397.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000266397.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000266401.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000266445.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000266446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000266469.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000266538.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000266644.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000266644.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000266677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000266709.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000266824.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000266830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000266850.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000266897.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000266900.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000266911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000266912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000266918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000266921.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000266926.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000266942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000266957.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000266970.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000266970.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000266975.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000266975.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000266994.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000266994.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000267002.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000267003.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000267009.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000267015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000267016.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000267018.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000267052.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000267054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267058.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000267064.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267065.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000267082.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000267082.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000267118.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000267138.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267143.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000267143.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000267149.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000267150.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000267152.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267159.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000267161.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000267167.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000267191.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000267198.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267199.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267201.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000267213.3 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000267214.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000267221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000267254.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267263.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000267265.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000267277.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000267289.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000267298.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000267317.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267342.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000267344.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000267374.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000267375.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000267424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000267446.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000267470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000267474.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000267474.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000267474.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267475.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000267476.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000267481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267505.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000267510.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000267510.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000267522.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000267530.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000267530.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000267530.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000267547.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000267560.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000267565.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000267581.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000267606.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267637.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000267638.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000267640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267655.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000267705.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000267729.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000267731.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000267737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000267745.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000267749.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000267758.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267758.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000267778.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000267808.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267834.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000267852.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267871.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000267874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000267898.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000267940.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000268049.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000268095.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000268189.2 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000268199.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000268199.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000268201.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000268201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000268230.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000268340.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000268362.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000268364.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000268392.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000268401.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000268471.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000268471.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000268471.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000268530.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000268568.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000268573.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000268573.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000268683.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000268743.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000268912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000268938.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000268945.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000268947.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000268947.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000268970.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000268981.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000269038.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000269038.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000269086.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000269091.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000269102.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000269161.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000269202.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000269290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000269290.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000269293.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000269321.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000269392.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000269397.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000269423.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000269427.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000269463.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000269481.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000269489.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000269534.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000269535.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000269614.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000269640.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000269646.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000269680.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000269694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000269752.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000269806.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000269814.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000269814.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000269815.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000269825.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000269843.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000269894.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000269896.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000269901.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000269911.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000269918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000269921.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000269938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000269942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000269946.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000269951.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000269956.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000269966.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000269970.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000269980.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000269983.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000269983.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000269990.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000269996.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000269997.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000269999.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000270006.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000270015.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000270018.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000270039.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000270049.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000270050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000270055.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000270061.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000270061.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000270062.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000270069.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000270072.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000270076.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000270081.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000270081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000270095.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000270103.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000270105.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000270108.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000270108.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000270116.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000270127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000270130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000270140.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000270143.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000270145.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000270154.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000270157.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000270173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000270189.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000270195.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000270223.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000270223.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000270246.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000270332.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000270346.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000270361.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000270362.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000270426.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000270522.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000270557.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000270557.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000270562.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000270571.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000270589.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000270681.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000270681.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000270704.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000270720.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000270820.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000270933.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000270964.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000270988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000271032.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000271109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271109.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000271119.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000271127.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000271147.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000271151.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000271199.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000271200.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271270.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271327.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000271335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271344.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000271347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271366.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000271387.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271420.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000271430.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000271553.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000271554.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271555.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000271576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271631.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000271738.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000271751.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000271755.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000271780.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000271789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271815.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000271825.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000271830.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271830.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000271830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000271843.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000271845.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271849.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000271851.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000271913.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000271914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271927.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000271948.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000271948.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000271963.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271963.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000271964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271966.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000271966.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000271971.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271981.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000271983.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000271998.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000272003.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000272005.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272010.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000272010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000272024.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272030.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272040.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272065.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000272076.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272088.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000272092.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000272103.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272103.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272108.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272112.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000272130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272137.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272143.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000272143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272144.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000272158.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272183.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000272205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272216.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272217.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000272226.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000272226.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000272235.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272240.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272255.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272263.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272264.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272301.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000272308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272316.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272343.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000272346.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272354.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000272365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272368.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272369.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000272375.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272377.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000272379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272382.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000272402.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000272411.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272420.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272426.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272430.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000272447.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000272452.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272455.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000272506.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272524.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272525.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000272537.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000272558.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272562.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272562.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272574.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000272574.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272576.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000272619.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272630.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272644.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272689.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000272695.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000272702.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000272717.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272732.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272734.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272744.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000272754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272755.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000272758.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272777.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000272782.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272787.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272792.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272792.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000272798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272799.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272800.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000272812.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272829.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000272846.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272849.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000272859.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272862.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272866.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000272871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272872.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272872.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272892.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000272902.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272915.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000272917.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000272927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272940.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000272950.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272954.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000272960.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| GSK1904529A |
ENSG00000272966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272977.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000272983.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273000.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000273004.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000273009.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000273015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273017.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273032.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000273033.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273044.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000273056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273065.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000273066.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273073.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000273075.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273102.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000273108.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273112.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK1904529A |
ENSG00000273117.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000273131.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000273142.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273148.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273148.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK1904529A |
ENSG00000273162.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000273176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273179.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000273183.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000273193.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273203.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273232.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000273237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273243.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000273245.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000273265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273287.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273290.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000273290.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273306.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273319.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273341.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| GSK1904529A |
ENSG00000273342.1 |
Predicted lncRNA |
Sarcoma |
|
| GSK1904529A |
ENSG00000273343.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273348.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273350.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| GSK1904529A |
ENSG00000273368.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273374.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000273381.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273399.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273437.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273437.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273456.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| GSK1904529A |
ENSG00000273483.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK1904529A |
ENSG00000273486.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK1904529A |
ENSG00000273486.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| GSK1904529A |
ENSG00000273486.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK1904529A |
ENSG00000273488.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|